Skip to main content
. Author manuscript; available in PMC: 2024 Nov 1.
Published in final edited form as: FASEB J. 2023 Nov;37(11):e23251. doi: 10.1096/fj.202301122RR

Figure 5. Whole-body silencing Lpcat3 expression alters phospholipid composition in metabolic organs.

Figure 5.

A. Expression of Lpcat3 in different tissues of HFD-fed C57BL/6 mice subcutaneously injected with control and Lpcat3 targeting ASOs (n=6–12/group).

B-E. PC composition in the liver, muscle, WAT and BAT of HFD-fed mice injected with ASO (n=5/group).

F. Serum FGF21 levels in HFD-fed mice injected with ASO (n=10/group).

Data are presented as means ± SEM. Statistical analysis was performed with Student’s t test. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.